Immunic Inc (NASDAQ: IMUX) is -12.00% lower on its value in year-to-date trading and has touched a low of $0.95 and a high of $3.11 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IMUX stock was last observed hovering at around $1.30 in the last trading session, with the day’s gains setting it 0.02%.
Currently trading at $1.32, the stock is -4.64% and 2.35% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.21 million and changing 1.54% at the moment leaves the stock -12.20% off its SMA200. IMUX registered -9.59% loss for a year compared to 6-month loss of -9.59%. The firm has a a 200-day simple moving average (SMA200) of -$0.74.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -5.71% gain in the last 1 month and extending the period to 3 months gives it a -17.50%, and is -1.49% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.59% over the week and 6.66% over the month.
Immunic Inc (IMUX) has around 77 employees, a market worth around $118.71M and $0.00M in sales. Distance from 52-week low is 39.67% and -57.56% from its 52-week high. The company has generated returns on investments over the last 12 months (-316.58%).
Immunic Inc quarterly earnings per share for the current quarter are estimated at -$0.26.The EPS is expected to grow by 52.61% this year
67 institutions hold shares in Immunic Inc (IMUX), with institutional investors hold 62.92% of the company’s shares. The shares outstanding are 89.93M, and float is at 83.16M with Short Float at 2.98%. Institutions hold 58.07% of the Float.
The top institutional shareholder in the company is RTW Investments LP with over 4.29 million shares valued at $10.78 million. The investor’s holdings represent 9.63% of the IMUX Shares outstanding. As of Jun 29, 2023, the second largest holder is Omega Fund Management, Llc with 1.79 million shares valued at $4.49 million to account for 4.01% of the shares outstanding. The other top investors are Gratus Capital LLC which holds 1.68 million shares representing 3.76% and valued at over $4.21 million, while Vanguard Group Inc holds 3.76% of the shares totaling 1.68 million with a market value of $4.21 million.
Immunic Inc (IMUX) Insider Activity
The most recent transaction is an insider purchase by Whaley Glenn, the company’s Chief Financial Officer. SEC filings show that Whaley Glenn bought 5,000 shares of the company’s common stock on May 15 ’23 at a price of $1.75 per share for a total of $8750.0. Following the purchase, the insider now owns 25510.0 shares.
